PTHS: Pelthos Therapeutics Inc. Company Profile & Statistics

Pelthos Therapeutics Inc. Profile

About

Pelthos Therapeutics is a biopharmaceutical company. Its lead product includes ZELSUVMI(TM) topical gel. Pelthos Therapeutics, formerly known as Channel Therapeutics Corporation, is based in DURHAM, N.C.

Info & Links

CEO

Francis Knuettel II

Headquarters

4400 Route 9 South, Suite 1000
Freehold, NJ 07728, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

Pelthos Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization²

80.83M

Enterprise Value

66.58M

Enterprise Value/EBITDA(ttm)

-3.20

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

1.34

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

17.18%

Operating Margin(ttm)

Profit Margin(ttm)

-54.81%

Return on Equity(ttm)

-210.32%

Return on Invested Capital(ttm)

143.11%

Return on Assets(ttm)

-72.82%

Income Statement

Revenue(ttm)

7.41M

Revenue Per Share(ttm)

2.42

Gross Profit(ttm)

5.09M

EBITDA(ttm)³

-20.77M

Net Income Available to Common(ttm)

-23.58M

Diluted EPS(ttm)

-17.08

Share Statistics

Beta (5Y Monthly)

3.92

52-Week Change

S&P 500 52-Week Change

11.77%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

3.06M

Dividend Yield

0.00%

Float⁴

2.56M

% Held by Insiders

16.40%

% Held by Institutions

77.96%

Balance Sheet

Total Cash(mrq)

14.25M

Total Cash Per Share(mrq)

4.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.01%

Quick Ratio(mrq)

1.04%

Book Value Per Share(mrq)

18.85

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.34

Free Cash Flow(ytd)

-16.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PTHS

Pelthos Therapeutics Inc.